Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07457372 · ClinicalTrials.gov registry record · NA
How Does Vagus Nerve Stimulation Affect Blood Glucose, Food, and Movement Cravings?
A NA study, sponsored by University of Minnesota.
- Not yet
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT07457372: Clinical Trial NA study, sponsored by University of Minnesota.
NCT07457372 is a NA study that has not yet begun recruiting, run by University of Minnesota. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07457372, a NA study, has not yet begun recruiting, sponsored by University of Minnesota.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the feasibility of using non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) to examine physiological and psychological responses in a college-aged healthy population
Interventions
- DEVICE Sham taVNS
- DEVICE Active taVNS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2026-09-01 |
| Est. Completion | 2028-05-01 |
| Phase | NA |
What is known before NCT07457372 opens enrollment
NCT07457372 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham taVNS is the first listed.
NCT07457372 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07457372 about?
NCT07457372 is a clinical study titled "How Does Vagus Nerve Stimulation Affect Blood Glucose, Food, and Movement Cravings?". The purpose of this study is to determine the feasibility of using non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) to examine physiological and psychological responses in a college-aged healthy population
What is the current status of trial NCT07457372?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 8 participants. The study started on 2026-09-01. Estimated completion is 2028-05-01.
What interventions are being tested in trial NCT07457372?
The interventions under investigation include: Sham taVNS (DEVICE), Active taVNS (DEVICE).
Who is sponsoring clinical trial NCT07457372?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07457372's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI